NOVARTIS PHARMA
0459.093.476 · rovalta.com · 25/09/2026
NOVARTIS PHARMA
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBONOVARTIS PHARMA is a Public limited company incorporated in 1996. Its registered office is in Machelen (Brab.). It employs on average 207,8 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0459.093.476
- Incorporation
- 25/10/1996
- Legal form
- Public limited company
- Registered office
- Kouterveldstraat 2
1831 Machelen (Brab.) · FlandreSee on map - Contributed capital
- 10 170 314,07 €
- Latest accounts
- 31/12/2025
- Average workforce
- 207,8 ETP
Joint committees (2)
- 200
- 218
Financials
Source · NBB, 21 filingsTrend over 15 financial years
| 2025 | 2024 | 2023 | 2022 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 378,6 M € | +6.2% | 356,5 M € | +4.7% | 340,6 M € | +5.1% | 324 M € | +2.8% | 315,2 M € |
| EBITDA | 12,1 M € | -27.4% | 16,7 M € | -37.2% | 26,5 M € | +2728% | 937,8 k € | -88.4% | 8,1 M € |
| Operating result | 15 M € | +6.7% | 14 M € | -52.2% | 29,3 M € | +515% | 4,8 M € | -45.3% | 8,7 M € |
| Net result | 11,5 M € | -14.2% | 13,4 M € | -48.5% | 26,1 M € | +878% | -3,4 M € | -279% | 1,9 M € |
| Balance sheet | |||||||||
| Equity | 32,1 M € | -31.8% | 47,1 M € | +39.9% | 33,7 M € | -53.6% | 72,6 M € | +552% | 11,1 M € |
| Total assets | 168,8 M € | +11.1% | 151,9 M € | -6.2% | 162 M € | -0.9% | 163,4 M € | +15.6% | 141,4 M € |
| Cash | 67,2 k € | -0.3% | 67,4 k € | -0.1% | 67,5 k € | -54.8% | 149,5 k € | +406% | 29,5 k € |
| Debts | 132,2 M € | +37.0% | 96,5 M € | -7.2% | 103,9 M € | +114% | 48,5 M € | -52.6% | 102,2 M € |
| Other | |||||||||
| Workforce | 207,8 ETP | -1.1% | 210,1 ETP | -9.2% | 231,4 ETP | -17.3% | 279,8 ETP | -12.4% | 319,4 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20253 active · 26 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 05/06/2026 | 06/06/2025 | 06/06/2024 | 07/06/2023 | 03/06/2022 | 26/10/2021 |
| General meeting | 04/06/2026 | 05/06/2025 | 06/06/2024 | 01/06/2023 | 02/06/2022 | 03/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 21 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 04/06/2026 | 05/06/2026 | Dutch | |
| Full model | 31/12/2024 | 05/06/2025 | 06/06/2025 | Dutch | |
| Full model | 31/12/2023 | 06/06/2024 | 06/06/2024 | Dutch | |
| Full model | 31/12/2022 | 01/06/2023 | 07/06/2023 | Dutch | |
| Full model | 31/12/2021 | 02/06/2022 | 03/06/2022 | Dutch | |
| Full modelCorrection | 31/12/2020 | 03/06/2021 | 26/10/2021 | Dutch | |
| Full model | 31/12/2020 | 03/06/2021 | 17/06/2021 | Dutch | |
| Full model | 31/12/2019 | 04/06/2020 | 12/06/2020 | Dutch | |
| Full model | 31/12/2018 | 06/06/2019 | 07/06/2019 | Dutch | |
| Full model | 31/12/2017 | 07/06/2018 | 12/06/2018 | Dutch | |
| Full model | 31/12/2016 | 01/06/2017 | 07/07/2017 | Dutch | |
| Full model | 31/12/2015 | 02/06/2016 | 27/06/2016 | Dutch | |
| Full model | 31/12/2014 | 04/06/2015 | 07/07/2015 | Dutch | |
| Full model | 31/12/2013 | 05/06/2014 | 12/06/2014 | Dutch | |
| Full model | 31/12/2012 | 06/06/2013 | 20/06/2013 | Dutch | |
| Full model | 31/12/2011 | 07/06/2012 | 12/12/2012 | Dutch | |
| Full model | 31/12/2010 | 06/06/2011 | 26/07/2011 | Dutch | |
| Full model | 31/12/2009 | 03/06/2010 | 13/07/2010 | Dutch | |
| Full model | 31/12/2008 | 26/06/2009 | 16/07/2009 | Dutch | |
| Full model | 31/12/2007 | 05/06/2008 | 11/07/2008 | Dutch | |
| Full model | 31/12/2006 | 07/06/2007 | 22/06/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 50 M€ and 100 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20253 active · 26 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates17/09/2026Ontslag - Benoeming Bestuurders - Volmacht
- Registered office15/05/2026MAATSCHAPPELIJKE ZETEL
- Registered office27/04/2026MAATSCHAPPELIJKE ZETEL
- Mandates22/09/2025ONTSLAGEN - BENOEMINGEN
- Mandates26/06/2025ONTSLAGEN - BENOEMINGEN
- Mandates30/08/2023ONTSLAGEN - BENOEMINGEN
- Capital / shares20/06/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Capital / shares02/01/2023KAPITAAL - AANDELEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202511,5 M €↓
- 27/08/2025nominationFederico Mambretti — bijzondere volmacht
- 27/08/2025nominationAndrea Majocchi — bijzondere volmacht
- 27/08/2025nominationNicolas Istas — bijzondere volmacht
- 27/08/2025nominationThomas Chretien — bijzondere volmacht
- 27/08/2025nominationMarlies Engelen — bijzondere volmacht
- 05/06/2025reconductionKPMG Bedrijfsrevisoren BV — commissaris
- 2024Annual accounts 202413,4 M €↓
- 2023Annual accounts 202326,1 M €↑
- 07/07/2023demissionRebecca De Luca — bijzondere volmacht
- 07/07/2023demissionPeter Gouverneur — bijzondere volmacht
- 07/07/2023nominationFederico Mambretti — President Belgium and Luxembourg / bijzondere volmacht
- 07/07/2023nominationAndrea Majocchi — CCFO Belgium and Luxembourg / bijzondere volmacht
- 07/07/2023nominationNicolas Istas — Country Head of Legal Belgium and Luxembourg / bijzondere volmacht
- 07/07/2023nominationRebecca De Luca — Business Excellence & Execution Head / bijzondere volmacht
- 07/07/2023nominationPeter Gouverneur — KAM, Tendering & Established Brands Lea / bijzondere volmacht
- 15/06/2023reduction_capital
- 2022Annual accounts 2022-3,4 M €↓
- 19/12/2022augmentation_capital
- 01/07/2022nominationNicolas Istas — bestuurder
- 02/06/2022nominationKPMG Bedrijfsrevisoren BV — commissaris
- 01/03/2022nominationNicola Bencini — bestuurder
- 01/03/2022nominationAndrea Majocchi — bestuurder
- 03/05/2021demissionPhilippe de Pougnadoresse — bijzondere volmacht
- 03/05/2021demissionNicolas Thiriet — bijzondere volmacht
- 03/05/2021demissionMichel Geelhand — bijzondere volmacht
- 03/05/2021demissionNicolas Istas — bijzondere volmacht
- 2020Annual accounts 20201,9 M €↓
- 2019Annual accounts 20194,6 M €↑
- 2018Annual accounts 20182,4 M €↓
- 2015Annual accounts 20152,5 M €↓
- 2014Annual accounts 20143,8 M €↓
- 2013Annual accounts 20136,1 M €↑
- 2012Annual accounts 20121 M €↑
- 2011Annual accounts 2011-275 k €↓
- 2010Annual accounts 20108,1 M €↓
- 2009Annual accounts 200910 M €↑
- 2008Annual accounts 20089 M €
- 25/10/1996IncorporationPublic limited company